mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.007 |
mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
0.5 |
0.007 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.007 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.009 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.009 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.009 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |